Marksans Pharma Ltd.

NSE: MARKSANS | BSE: 524404 | ISIN: INE750C01026 | Industry: Pharmaceuticals
| Mid-range Performer
256.1500 1.00 (0.39%)
NSE Jun 03, 2025 14:03 PM
Volume: 591.3K
 

256.15
0.39%

Marksans Pharma

Centrum Broking
Recommendation and key risks: We have revised our FY18E and FY19E EPS downwards by 3% and 19% respectively. We upgrade MPL to Buy from Hold rating, with a TP of Rs55 based on 18x March'20E EPS of Rs3.0, and a 45.3% upside from CMP. Key positive upsides would be additional ANDA approvals from US FDA and...
Marksans Pharma Ltd. is trading above its 100 day SMA of 233.0
More from Marksans Pharma Ltd.
Recommended